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EDITORIALS
Vulnerability and Genetic Susceptibility to Cigarette Smoke–Induced
Emphysema in Mice
Cigarette smoke (CS) has been identiﬁed as the most important
risk factor for the development of chronic obstructive pulmonary
disease (COPD). Studies of cigarette/tobacco smoke–induced
COPD have primarily utilized small laboratory animals,
particularly inbred laboratory mice, as the model of choice. The
ﬁrst comprehensive review of animal models of emphysema
relating to the pathogenesis of COPD was published in 2002 (1),
and a more recent review provided updates on this topic (2).
The use of this species has several advantages, including a
relatively low cost, a rapid reproductive cycle, large litter sizes, and the
availability of antibodies and molecular probes developed speciﬁcally
for mouse research. In addition, many inbred strains and their
mutants (transgenic and knockout) are available and a high overall
genetic homology exists between the mouse and human genomes.
Finally, mouse genes can be manipulated to create global as well as
conditional mutants (using CRISPR/Cas and tissue-speciﬁc Cre
transgenes). However, the mouse has limitations as an animal model
of COPD in that it does not fully recapitulate the human disease. One
should keep this limitation in mind when planning experiments and
interpreting results obtained in this species (3).
Importantly, mice are obligatory nose breathers, so they exhibit
a different pattern of particle ﬁltration in the nares and upper
respiratory tract compared with humans. However, this does not
invalidate the methods commonly used to expose mice to
cigarette/tobacco smoke, i.e., by nose only and by whole body,
because both approaches model second-hand smoke exposure.
Moreover, mouse submucosal glands are restricted to the
trachea, and mice lack a signiﬁcant population of goblet cells in their
bronchi and bronchioles. The appearance of clusters of goblet cells in
their bronchi/bronchioles after cigarette/tobacco smoke exposure is
likely due to metaplasia and not hyperplasia. Additionally, mice do not
have respiratory bronchioles and therefore lack the anatomical basis for
the development of centrilobular emphysema, a lesion of respiratory
bronchioles. Instead, they develop patchy emphysema.
Mice can be exposed to CS delivered by a smoking machine via
nose-only (4) or whole-body (5) exposure. The types of cigarettes,
chemical emissions, and particulates used, the number of cigarettes
smoked per day, and the duration of exposure (in months) have
not been standardized, so these aspects differ among laboratories.
Generally, either reference (R series) cigarettes from the Kentucky
Tobacco Research and Development Center at the University of
Kentucky (Lexington, KY) or the commercially available Marlboro
Red cigarettes are used. The latter have the advantage of being
widely available and commonly used by smokers. CS studies have
provided a fundamental understanding of the complex pathogenic
cellular and molecular processes, including genetic/epigenetic
mechanisms, that are involved in the development of COPD and
the testing of potential therapeutics.
Not all strains of mice develop emphysema after chronic CS
exposure. In susceptible strains, the severity of emphysema is limited
and does not reach the extent seen in human smokers or in other
murine models of emphysema. The different susceptibilities to
emphysema observed in three strains of mice have been linked to
strain-dependent differences in antioxidant defenses in response to CS
(6). ICR mice were shown to have increased lung antioxidant defenses
(possibly Nrf2, glutathione, glutaredoxin-1, and peroxiredoxin-6)
when acutely exposed to CS, whereas C57BL/6J and DBA2 mice did
not (6). Of interest, C57BL/6J and DBA2 mice developed signiﬁcant
emphysema when exposed to CS for 6–7 months, whereas ICR
mice did not (6). Chronic CS exposure causes other cellular
alterations; for example, impaired ciliated epithelial cell function was
observed in C57BL/6J mice exposed to whole-body CS for up to 1 year
(7). Another study of several mouse strains (i.e., NZWLac/J, A/J, SJ/L,
and AKR/J) conﬁrmed the strain dependency response to CS and
identiﬁed other emphysema-resistant or susceptible strains
(8). However, the genetic basis for that variability has not been studied.
Recently, a recombinant inbred strain of mice, referred to as the
Collaborative Cross (CC), was derived from random mixing of eight
different founder strains (9). This CC strain has a high phenotypic
diversity that closely mimics human disparity/diversity, thus
enhancing investigators’ ability to map the causative loci underlying
complex disease-related traits (9). Future studies using the CC strain
will provide a better understanding of tobacco/CS-induced
COPD/emphysema models at the level of systems genetics.
In this issue of the Journal, Radder and colleagues (pp. 367–
375) show that susceptibility to CS-induced emphysema as
measured by alveolar chord length is a variable and continuous
trait in 34 inbred strains of mice (10). They demonstrate various
degrees of susceptibility, ranging from no response (resistant
CBA/J) to extremely susceptible (A/J). The C57BL/6J mice were the
second most susceptible to CS. By testing the association of this
quantitative trait across the genome and then integrating mouse
and human genome-wide scans, Radder and colleagues identiﬁed
Abi3bp as a novel candidate gene contributing to emphysema
susceptibility. This gene encodes for ABI family member 3 binding
protein (also known as TARSH or eratin), a putative tumor
suppressor that is predominantly expressed in the lung.
Intriguingly, this protein controls the growth and differentiation of
stem and tumor cells while it also promotes senescence in some
cells via a p21-dependent pathway (11). Cellular senescence is one
of several molecular mechanisms that have been shown to mediate
COPD pathogenesis (12). The potential role of the Abi3bp gene in
pulmonary emphysema requires more investigation in humans and
laboratory animals (i.e., knockout mice for Abi3bp) to establish the
mechanistic contribution of this gene to emphysema susceptibility.
In addition to the study limitations identiﬁed by the authors,
only female mice were used, and sex-speciﬁc differences may be
important (13). Also, the authors were unable to detect any
regions that strictly met multiple testing correction thresholds.
Importantly, alveolar chord length is not a correlate/measure for
emphysema, and emphysema is only one pathological entity of
COPD. The moderate functional and anatomical responses to
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chronic CS exposure in animals are certainly another important
limiting factor. There is a lack of information about various lung
mechanical properties (e.g., compliance, resistance, and pressure-
volume), although the authors used the ﬂexiVent system (SCIREQ,
Montreal, Quebec, Canada) for forced oscillatory mechanics
measurements and provided the tissue elastance H data.
Nevertheless, the ﬁndings in this study point to a novel intrinsic
factor that may be an important determinant of the disease course.
COPD is a collection of conditions, including emphysema,
chronic bronchitis, mucus hypersecretion, bronchiolar and vascular
remodeling, and sometimes the development of ﬁbrotic areas
scattered throughout the parenchyma, that frequently coexist in
humans with this disease. Remarkable variation in the manifestation
of COPD is observed among individuals with regard to the severity
of symptoms and the rate of decline in FEV1 (14). Understandably,
it is challenging to expect experimental rodent models to fully
recapitulate the diverse aspects of the disease in humans.
Future research should seek to identify the basis of COPD
exacerbations and clarify the pathophysiological processes that
contribute to the multiple phenotypes (susceptibility, severity, rate of
progression, propensity to experience exacerbations, and emphysema
versus chronic bronchitis) caused by CS or by ﬂavored tobacco
products such as electronic nicotine delivery systems, cigars, and
waterpipes/hookahs. Different genetic loci may contribute to different
aspects of the disease, and may or may not be the same as those
that determine susceptibility. Animal models constitute essential tools
because they can be used to study a deﬁned phenotype and to identify
novel candidate genes. In that regard, mouse strains that develop
CS-induced emphysema with or without goblet cell metaplasia, or
that develop emphysema with pulmonary ﬁbrosis or emphysema
associated with pulmonary hypertension are currently available.
The use of relevant mouse strains may thus help to identify candidate
genes of probable biological relevance for the pathophysiology of a
deﬁned phenotype, and to inform human studies seeking to identify
gene linkage quantitative trait locus with COPD (9, 10). n
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